| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-08 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |